Register now!

Research Policy Working Group      Policy Development Working Group      EU/US/Asia Pacific Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine. The VPH Institute has its origins as an EU funded DG Connect project and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

Avicenna Alliance’s Secretary General to give keynote speech at ICCAI 2017

On 27-29 July 2017, the Society for Complex Acute Illness (SCAI) will organise the 16th annual International Conference on...

find out more ›

Avicenna Alliance represented at eHealth week in Malta!

The Avicenna Alliance has been invited to participate in a session dedicated to in silico trials on 12 May 2017 during the eHealth week in...

find out more ›

Avicenna Alliance invited to Joint Research Centre (JRC) Round Table Meeting in Ispra

The Joint Research Centre (JRC) located in Ispra, Italy organised a Round table meeting on 7 March 2017 to...

find out more ›

Show all activites